Skip to main content
Anoro Ellipta-H-C-PSR-S-0048: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Anoro Ellipta-H-C-PSR-S-0048: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

59 wyświetleń
Pobierz
Farmaceutyczny

Anoro Ellipta-H-C-PSR-S-0048: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Zaawansowana formuła farmaceutyczna do celowanego działania terapeutycznego.

Dawkowanie

Anoro Ellipta-H-C-PSR-S-0048: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Moc

Anoro Ellipta-H-C-PSR-S-0048: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Wielkość opakowania

Anoro Ellipta-H-C-PSR-S-0048: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Postać

Anoro Ellipta-H-C-PSR-S-0048: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Źródło

European Medicines Agency

Zobacz źródło

Profil bezpieczeństwa

Przeciwwskazania

Anoro Ellipta-H-C-PSR-S-0048: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Skutki uboczne

Anoro Ellipta-H-C-PSR-S-0048: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Powiązane artykuły kliniczne

Skanuj ten kod QR, aby szybko uzyskać dostęp do tej strony na swoim urządzeniu mobilnym.

QR Code